Cenamps have announced that a
Tyneside firm has joined forces with a leading Japanese electronics
manufacturer to develop a new range of ground-breaking, hi-tech devices
to provide "nearer the patient" diagnoses of a range of diseases.
With the help of UK Trade & Investment's "Passport to
Export" programme, early-stage nano biotechnology firm Orla Protein
Technologies Ltd (Orla) has signed an agreement with the Japan Radio
Co. Ltd (JRC), in Tokyo, to develop the new devices that can be used by
doctors and paramedics to allow earlier and more effective treatment
for patients, without the need for complex equipment.
Simple to use, small, low-cost and portable the devices can
provide instant test results for viruses, bacteria and protein markers.
Test results will be stored electronically and can be capable of
wireless transmission, opening significant opportunities in the
multi-million dollar diagnostics market.
Dale Athey, Chief Executive at Orla, explained:"This is a very
exciting development for Orla and we are honoured to have a partner
such as JRC. Their expertise in mass manufacture and sensor technology,
combined with Orla's novel bio surface technology provides a fantastic
opportunity to create a leading position in the bio diagnostic market."
Jeff Sanders, one of UK Trade & Investments
International Trade Advisers, said: "We have been working with Orla for
the past five years and have helped them develop a comprehensive export
plan, that helped maximise the support available through UK Trade
& Investment, including its Passport to Export programme.
"This carefully planned approach to international trade has
been vital element of the company's success and its great to see that
their hard work is now paying dividends. The partnership with JRC is an
important development and we will continue to offer all the support we
can to ensure its on going success."
Posted 3rd December 2007
